Utilization of Vertebroplasty/ Kyphoplasty in the Management of Compression Fractures: National Trends and Predictors of Vertebroplasty/Kyphoplasty

被引:2
作者
O'Neill, Brannan E. [1 ]
Godil, Jamila A. [1 ]
Smith, Spencer [2 ]
Rae, Ali I. [1 ]
Wright, Christina H. [1 ]
Wright, James M. [1 ]
Ross, Donald A. [1 ]
Orina, Josiah N. [1 ]
Liu, Jesse J. [1 ]
Lin, Clifford [2 ]
Philipp, Travis C. [2 ]
Kark, Jonathan [2 ]
Yoo, Jung U. [2 ]
Ryu, Won Hyung A. [1 ,3 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Neurol Surg, Portland, OR USA
[2] Oregon Hlth & Sci Univ, Dept Orthoped & Rehabil, Portland, OR USA
[3] Oregon Hlth & Sci Univ, Dept Neurol Surg, Mail Code CH8N,3303 South Bond Ave, Portland, OR 97239 USA
关键词
Compression fracture; Kyphoplasty; Vertebroplasty; Osteoporosis;
D O I
10.14245/ns.2346804.402
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: The purpose of this study is to examine the utilization of kyphoplasty/vertebroplasty procedures in the management of compression fractures. With the growing elderly population and the associated increase in rates of osteoporosis, vertebral compression fractures have become a daily encounter for spine surgeons. However, there remains a lack of consensus on the optimal management of this patient population.Methods: A retrospective analysis of 91 million longitudinally followed patients from 2016 to 2019 was performed using the PearlDiver Patient Claims Database. Patients with compression fractures were identified using International Classification of Disease, 10th Revision codes, and a subset of patients who received kyphoplasty/vertebroplasty were identified using Common Procedural Terminology codes. Baseline demographic and clinical data between groups were acquired. Multivariable regression analysis was performed to determine predictors of receiving kyphoplasty/vertebroplasty.Results: A total of 348,457 patients with compression fractures were identified with 9.2% of patients receiving kyphoplasty/vertebroplasty as their initial treatment. Of these patients, 43.5% underwent additional kyphoplasty/vertebroplasty 30 days after initial intervention. Patients receiving kyphoplasty/vertebroplasty were significantly older (72.2 vs. 67.9, p < 0.05), female, obese, had active smoking status and had higher Elixhauser Comorbidity Index scores. Multivariable analysis demonstrated that female sex, smoking status, and obesity were the 3 strongest predictors of receiving kyphoplasty/vertebroplasty (odds ratio, 1.27, 1.24, and 1.14, respectively). The annual rate of kyphoplasty/vertebroplasty did not change significantly (range, 8%-11%).Conclusion: The majority of vertebral compression fractures are managed nonoperatively. However, certain patient factors such as smoking status, obesity, female sex, older age, osteoporosis, and greater comorbidities are predictors of undergoing kyphoplasty/vertebroplasty.
引用
收藏
页码:1132 / 1139
页数:8
相关论文
共 9 条
  • [1] Difference in the Cobb Angle Between Standing and Supine Position as a Prognostic Factor After Vertebral Augmentation in Osteoporotic Vertebral Compression Fractures
    Bae, In-Suk
    Moon, Byung Gwan
    Kang, Hee In
    Kim, Jae Hoon
    Jwa, Cheolsu
    Kim, Deok Ryeong
    [J]. NEUROSPINE, 2022, 19 (02) : 357 - 366
  • [2] The Rise and Fall of Bone Morphogenetic Protein 2 Throughout the United States
    Beschloss, Alexander M.
    DiCindio, Christina M.
    Lombardi, Joseph S.
    Shillingford, Jamal N.
    Laratta, Joseph L.
    Holderread, Brendan
    Louie, Phillip
    Pugely, Andrew J.
    Sardar, Zeeshan
    Khalsa, Amrit S.
    Arlet, Vincent M.
    Saifi, Comron
    [J]. CLINICAL SPINE SURGERY, 2022, 35 (06): : 264 - 269
  • [3] Safety and Efficacy of Recombinant Human Bone Morphogenetic Protein-2 in Multilevel Posterolateral Lumbar Fusion in a Prospective, Randomized, Controlled Trial
    Choi, Ho Yong
    Hyun, Seung-Jae
    Lee, Chang Hyun
    Youn, Ji Hyun
    Ryu, Mi Young
    Kim, Ki-Jeong
    [J]. NEUROSPINE, 2022, 19 (03) : 838 - 846
  • [4] Dose Adjustment Associated Complications of Bone Morphogenetic Protein: A Longitudinal Assessment
    De Stefano, Frank A.
    Elarjani, Turki
    Burks, Joshua D.
    Burks, Stephen S.
    Levi, Allan D.
    [J]. WORLD NEUROSURGERY, 2021, 156 : E64 - E71
  • [5] Anabolic agents: what is beyond osteoporosis?
    Liu, Y.
    Levack, A. E.
    Marty, E.
    Or, O.
    Samuels, B. P.
    Redko, M.
    Lane, J. M.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2018, 29 (05) : 1009 - 1022
  • [6] A Randomized, Placebo-Controlled Study of Romosozumab for the Treatment of Hip Fractures
    Schemitsch, Emil H.
    Miclau, Theodore
    Karachalios, Theofilos
    Nowak, Lauren L.
    Sancheti, Parag
    Poolman, Rudolf W.
    Caminis, John
    Daizadeh, Nadia
    Dent-Acosta, Ricardo E.
    Egbuna, Ogo
    Chines, Arkadi
    Maddox, Judy
    Grauer, Andreas
    Bhandari, Mohit
    [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2020, 102 (08) : 693 - 702
  • [7] Bone remodeling: Multiple cellular interactions required for coupling of bone formation and resorption
    Sims, Natalie A.
    Gooi, Jonathan H.
    [J]. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2008, 19 (05) : 444 - 451
  • [8] Risk of Revision After Vertebral Augmentation for Osteoporotic Vertebral Fracture: A Narrative Review
    Takahashi, Shinji
    Inose, Hiroyuki
    Tamai, Koji
    Iwamae, Masayoshi
    Terai, Hidetomi
    Nakamura, Hiroaki
    [J]. NEUROSPINE, 2023, 20 (03) : 852 - 862
  • [9] Therapeutic Effect of Teriparatide for Osteoporotic Thoracolumbar Burst Fracture in Elderly Female Patients
    Yu, Dongwoo
    Kim, Sungho
    Jeon, Ikchan
    [J]. JOURNAL OF KOREAN NEUROSURGICAL SOCIETY, 2020, 63 (06) : 794 - 805